Aplagon is also planning for 2026 a Phase 2 clinical trial for arteriovenous fistula (AVF) maturation failure in Europe, following the successful completion of its Phase 1 AVF trial. The study ...

In the fight against leukemia, even the most advanced treatments carry a significant risk of the disease returning. Now, Chinese scientists have developed a kind of "double-sided tape" that helps the ...

New trial data suggest azacitidine-venetoclax may rival 7+3 in AML, shifting induction toward targeted, less toxic combinations.

Donald Trump appears to be so into his shoes he's forcing his loyal staff to partake in his obsession, RadarOnline. com can ...

Briumvi significantly outperformed Aubagio at reducing disease activity in people with highly active relapsing forms of MS, a ...

Howard University opens the first comprehensive wellness center for sickle cell disease in Washington, D.C., offering personalized care and support.

The Citizens Life Sciences Conference 2026 March 11, 2026 10:45 AM EDTCompany ParticipantsHelen Torley - President, ...

Atlas Salt Inc. is developing the Great Atlantic Salt Project, a huge underground salt mine in western Newfoundland with a life span of at least 24 years. Exporting the salt for road de-icing is ...

The blood–brain barrier functions as an evolutionarily optimized vascular “filter,” permitting limited penetration of small molecules like temozolomide while effectively excluding most biologics from ...

Major depressive disorder (MDD) is one of the leading causes of disability worldwide, and approximately 30% of patients develop treatment-resistant depression (TRD), a condition that does ...

A new furry faculty member has joined the children's hospital, ready to assist pediatric patients and their families during treatments.